• People
  • Practices
  • COVID-19 Resources
  • Insights
    • Firm News
    • Press Releases
    • Publications
    • Webcasts
    • Podcasts
    • Subscribe
    • Media Contacts
  • Careers
    • Career Opportunities
    • Attorney Development
    • Contact Us
  • About
    • Our Story
    • Awards & Accolades
    • Offices
    • Diversity
    • Pro Bono
    • Alumni
    • Contact Us
  • Search
  • Biography
  • Education
  • Recent Publications
Profile Picture

Reid Rector

Reid
Rector

Associate Attorney

CONTACT INFO

rrector@gibsondunn.com

TEL:+1 303.298.5923

FAX:+1 303.313.2821

Denver

1801 California Street, Suite 4200, Denver, CO 80202-2642 USA

  • Print
  • |
  • Share
  • |
  • vCard

PRACTICE

Litigation FDA and Health Care False Claims Act/Qui Tam Defense Life Sciences Privacy, Cybersecurity and Data Innovation White Collar Defense and Investigations

BIOGRAPHY

Reid Rector is an associate in the Denver office of Gibson, Dunn & Crutcher, where he is a member of the firm’s Litigation Department.  His practice focuses on litigation and government investigations for companies in the health care and technology industries, including health care and FDA compliance, enforcement, and related litigation, data security and consumer protection counseling and investigations, and complex civil litigation and class actions.

Mr. Rector has substantial experience representing health care, pharmaceutical, and medical device clients during investigations by the Department of Justice, the Food and Drug Administration, and the Department of Health and Human Services Office of Inspector General, including in-depth experience with the False Claims Act and Anti-Kickback Statute.  He also regularly advises clients on FDA regulatory issues under the Federal Food, Drug, and Cosmetic Act.  Additionally, Mr. Rector represent a variety of clients on data security and consumer protection issues, including in the class action context and in investigations before the Federal Trade Commission and the Department of Health and Human Services Office for Civil Rights.

Representative Health Care and FDA Experience

  • Represented a Fortune 500 hospital management company during an extensive national False Claims Act investigation by the Department of Justice and HHS Office of Inspector General
  • Represented a large Medicaid claims processing company in state health care fraud litigation
  • Advised a medical device and pharmaceutical company on FDA promotional and advertising issues
  • Represented a medical device company in False Claims Act investigations involving Anti-Kickback Statute and off-label promotion theories
  • Represented a major health care insurance company in a False Claims Act investigation
  • Conducted an internal investigation for a biopharmaceutical company related to FDA good manufacturing practices
  • Advised a consumer products company on FDA regulatory compliance

Representative Data Security and Consumer Protection Experience

  • Represented a large technology company in the wake of a data breach during a Federal Trade Commission investigation
  • Conducted an internal investigation at a large retailer after a data security incident
  • Advised a payment processing technology company on data security standards and requirements
  • Represented a technology and consumer products company in a Federal Trade Commission investigation
  • Advised a Fortune 500 health care company on HIPAA regulations and compliance
  • Advised a major health care insurance company on breach notification requirements in the wake of a data breach

Representative Litigation and Class Action Experience

  • Represented daily-fantasy sports company in complex class action litigation and multi-state Attorneys General investigations
  • Represented large technology company in class action litigation involving arbitration and class challenges
  • Represented media company in complex civil litigation involving breach of contract claims

Mr. Rector has successfully represented clients in state and federal courts, and before regulatory agencies, in connection with all of these areas, as well as in connection with claims for unfair competition, false advertising, government fraud, and breach of contract.  In addition, Mr. Rector has published several articles regarding the False Claims Act and data security standards.  Most recently, Mr. Rector has been recognized in the 2023 edition of Best Lawyers: Ones to Watch in America™ for Government Relations and Health Care Law practice.

Mr. Rector received his J.D., magna cum laude, from Georgetown University Law Center in 2013, where he was elected to the Order of the Coif and was a member of the Trial Advocacy Team. Mr. Rector graduated cum laude from the University of Notre Dame in 2005 with a B.A. in the Program of Liberal Studies.  After completing undergraduate work, Mr. Rector worked on human rights issues in Washington, D.C. and global health issues in Lesotho.

Mr. Rector serves on the Board of Directors for the Touching Tiny Lives Foundation and The Delores Project. In addition, he is actively involved in pro bono work in the local community.

Mr. Rector is admitted to practice law in the State of Colorado, as well as in the U.S. District Court for the District of Colorado.

EDUCATION

Georgetown University - 2013 Juris Doctor

University of Notre Dame - 2005 Bachelor of Arts

ADMISSIONS

Colorado Bar

RECENT PUBLICATIONS

Webcasts - January 11, 2023 | Webcast: Internal Investigations
Article - September 26, 2022 | Senators’ Call for Increased DOJ Use of Suspension and Debarment Could Impact False Claims Act Investigations
Client Alert - August 31, 2022 | Senators’ Call for Increased DOJ Use of Suspension and Debarment Could Impact False Claims Act Investigations and Resolutions
Client Alert - July 20, 2022 | 2022 Mid-Year False Claims Act Update
Client Alert - February 3, 2022 | 2021 Year-End False Claims Act Update
Client Alert - July 26, 2021 | 2021 Mid-Year False Claims Act Update
Client Alert - January 28, 2021 | U.S. Cybersecurity and Data Privacy Outlook and Review – 2021
Client Alert - January 27, 2021 | 2020 Year-End False Claims Act Update
Client Alert - July 17, 2020 | 2020 Mid-Year False Claims Act Update
Client Alert - April 13, 2020 | FDA Round-Up: Overview of Emergency Actions to Expedite the Availability of Medical Products to Combat COVID-19
Client Alert - January 31, 2020 | 2019 Year-End False Claims Act Update
Client Alert - January 27, 2020 | U.S. Cybersecurity and Data Privacy Outlook and Review – 2020
Client Alert - July 16, 2019 | 2019 Mid-Year False Claims Act Update
Client Alert - May 14, 2019 | Cooperation Credit in False Claims Act Cases: Opportunities and Limitations in DOJ’s New Guidance
Client Alert - February 12, 2019 | 2018 Year-End FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - January 28, 2019 | U.S. Cybersecurity and Data Privacy Outlook and Review – 2019
Publications - January 14, 2019 | U.S. Department of Health and Human Services Issues New Guidance on Voluntary Cybersecurity Practices for Health Care Industry
Client Alert - January 9, 2019 | 2018 Year-End False Claims Act Update
Client Alert - July 26, 2018 | 2018 Mid-Year FDA and Health Care Compliance and Enforcement Update – Providers
Client Alert - July 11, 2018 | 2018 Mid-Year False Claims Act Update
Client Alert - January 25, 2018 | U.S. Cybersecurity and Data Privacy Outlook and Review – 2018
Client Alert - January 23, 2018 | 2017 Year-End FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - January 5, 2018 | 2017 Year-End False Claims Act Update
Client Alert - September 4, 2017 | 2017 Mid-Year FDA and Health Care Compliance and Enforcement Update – Providers
Client Alert - August 25, 2017 | 2017 Mid-Year FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - August 8, 2017 | Cybersecurity & Data Privacy: An Overview for Health Care, Pharmaceutical, and Biotech Companies
Client Alert - July 12, 2017 | 2017 Mid-Year False Claims Act Update
Client Alert - February 15, 2017 | 2016 Year-End Health Care Compliance and Enforcement Update – Providers
Client Alert - January 31, 2017 | International Cybersecurity and Data Privacy Outlook and Review: 2017
Client Alert - January 27, 2017 | U.S. Cybersecurity and Data Privacy Outlook and Review: 2017
Client Alert - January 12, 2017 | 2016 Year-End FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - January 5, 2017 | 2016 Year-End False Claims Act Update
Article - October 27, 2016 | FCA Liability after Escobar: Challenges and Opportunities for Device Companies
Client Alert - August 2, 2016 | 2016 Mid-Year Health Care Compliance and Enforcement Update – Providers
Client Alert - July 27, 2016 | 2016 Mid-Year FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - July 7, 2016 | 2016 Mid-Year False Claims Act Update
Client Alert - January 19, 2016 | 2015 Year-End FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - January 6, 2016 | 2015 Year-End False Claims Act Update
Article - November 23, 2015 | Making Sense of a Morass: An Overview of the Different Standards U.S. Government Agencies and Other Entities Are Developing to Regulate Cybersecurity
Client Alert - August 13, 2015 | Another Successful Challenge to Restrictions on Off-Label Promotion
Client Alert - July 16, 2015 | 2015 Mid-Year FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - July 8, 2015 | 2015 Mid-Year False Claims Act Update
Client Alert - February 17, 2015 | Cybersecurity and Data Privacy Outlook and Review: 2015
Client Alert - February 12, 2015 | U.S. Antitrust Agencies Signal Increased Requirements for Merger Remedies
Client Alert - January 14, 2015 | 2014 Year-End Health Care Compliance and Enforcement Update – Providers
Client Alert - January 14, 2015 | 2014 Year-End FDA and Health Care Compliance and Enforcement Update – Drugs and Devices
Client Alert - January 7, 2015 | 2014 Year-End False Claims Act Update
  • Sitemap
  • Client Extranet
  • Legal Notices
  • Modern Slavery Statement
  • Privacy Policy
  • Cookie Notice
  • Contact Us
©Gibson, Dunn & Crutcher LLP 2023. All rights reserved.
Top